CNCR ETF
CNCR ETF
$9.02
Range Cancer Therapeutics ETF
AUM$7M
TER0.79%
Holdings67
See how much of CNCR you already own
CNCR ETF Performance
CNCR performance across multiple time periods: 1-month 6.52%, YTD -20.21%, 1-year -32.21%, 3-year -13.45%, 5-year -13.59%.
CNCR returns trail the peer average of -0.89% YTD. With an expense ratio of 0.79%, investors should weigh costs against performance when evaluating this ETF.
CNCR vs another fund shows side-by-side returns. CNCR alternatives are available in the ETF Screener.